Acute Mesenteric Ischemia Treatment & Management
- Author: Chat V Dang, MD; Chief Editor: John Geibel, MD, DSc, MSc, MA more...
Recognition of acute mesenteric ischemia (AMI) before permanent tissue damage occurs is the best way of improving patient survival, and only angiography or exploratory surgery makes early diagnosis possible. Computed tomography (CT) angiography (CTA) and magnetic resonance angiography (MRA) have become the cornerstones of modern diagnostic approach, allowing prompt laparotomy in patients with suspected AMI. A second-look procedure is indicated whenever bowel of questionable viability is not resected.
After initial medical or surgical stabilization, patients with AMI typically have a prolonged inpatient recovery time. This is especially true when resection of necrotic bowel is performed. Such patients may need to be kept on nil per os (NPO) status, and they may be maintained on parenteral nutrition for some time. If sepsis is evident, liver abscess should be actively sought. During the inpatient stay, every effort must be made to find and, if possible, treat any predisposing cause(s) of AMI.
Inpatient medications that may be used include the following:
Heparin/low-molecular-weight heparin (LMWH)
Broad-spectrum antibiotics and pain medications
Because timing is essential in preventing bowel necrosis with its attendant severe morbidity and mortality, patients should be transferred only if the primary hospital lacks adequate services for diagnosing and treating the patient. Patients should be optimally resuscitated before transfer. Appropriate services must be available at the receiving hospital.
In 2000, the American Gastroenterological Association released recommended algorithms for the diagnosis and management of mesenteric ischemia (see the images below). However, these recommendations were formulated before the availability of improved data from multidetector CT, as a result of which CT now plays a larger role in the diagnosis of mesenteric ischemia.
Treatment options depend on the etiology of intestinal ischemia, as well as on the hemodynamic stability of the patient and the experience/expertise of the treating staff. Generally speaking, nonocclusive AMI is treated medically, whereas occlusive AMI is correctable with surgery. Definitive treatment options include the following:
Acute mesenteric arterial embolism (AMAE) - Papaverine infusion, surgical embolectomy, and intra-arterial thrombolysis
Acute mesenteric arterial thrombosis (AMAT) - Papaverine infusion and arterial reconstruction, either through aortosuperior mesenteric arterial bypass grafting or through reimplantation of the superior mesenteric artery (SMA) into the aorta 
Nonocclusive mesenteric ischemia (NOMI) - Papaverine infusion [53, 64, 82]
Mesenteric venous thrombosis (MVT) - Anticoagulation with heparin or warfarin, either alone or in combination with surgery; immediate heparinization should be started even when surgical intervention is indicated [70, 37, 83, 65, 84, 33]
All cases of mesenteric ischemia with signs of peritonitis or possible bowel infarction, regardless of etiology, generally warrant immediate surgical intervention for the resection of ischemic or necrotic intestines. Hemodynamic instability can also be an indication for surgery. Surgical treatment may be contraindicated if the risks from comorbid conditions preclude survival after general anesthesia. If the ischemia is thought to be caused by vasospasm, surgery is not indicated. Medical management with anticoagulants and intra-arterial vasodilators is appropriate.
Some experience with percutaneous endovascular interventions has been accumulated. In select cases, especially in isolated spontaneous dissection of the SMA, stent placement may be the preferred option.
Aside from timely diagnosis and treatment of predisposing conditions, there are no known preventive measures for AMI. In the presence of a clinical syndrome suggesting chronic mesenteric insufficiency, color Doppler evaluation of the mesenteric vessels may help identify at-risk patients for further workup and determine which patients might need angioplasty.
Initial Resuscitation and Stabilization
Because patients with mesenteric ischemia are usually in a highly toxic state or rapidly progressing toward such a state, resuscitation is often necessary. Every effort should be made to improve patients’ cardiovascular status. Vasopressors should be avoided, because they worsen ischemia. Oxygen should be provided to maintain a saturation between 96-99%, via endotracheal intubation if necessary. Early intubation in unstable patients may improve oxygenation and allow more aggressive fluid resuscitation.
If hypovolemia is considered likely, intravenous (IV) fluid resuscitation is required. This is accomplished with isotonic sodium chloride solution, and blood products are provided as needed. Adequacy of resuscitation can be determined by means of urinary output, central venous pressure, or Swan-Ganz pressure monitoring. A nasogastric tube should be inserted, and any arrhythmia, congestive heart failure (CHF), or myocardial infarction (MI) should be treated.
All patients with possible bowel ischemia should be started on broad-spectrum antibiotics at an early stage to cover the possibility of bowel necrosis with contamination. Adequate pain control should be provided (eg, with parenteral opioid analgesics) while stable blood pressure is maintained.
Intra-arterial infusion of papaverine through the angiography catheter at the affected vessel is useful for all arterial forms of AMI. Papaverine is an opium derivative that functions as a phosphodiesterase inhibitor, which acts to relax vascular smooth muscle. It is usually infused directly into the superior mesenteric artery (SMA), thus improving intestinal blood flow.
An infusion of 30-60 mg/hr may be started after angiography, with the dosage subsequently adjusted on the basis of the clinical response. This should be continued for at least 24 hours. If the catheter slips into the aorta, significant hypotension can occur. It must be kept in mind that papaverine is incompatible with heparin.
Papaverine relieves reactive vasospasm in occluded arterial vessels and is the only treatment of NOMI other than resection of gangrenous bowel. In some patients with AMAE, intra-arterial papaverine has reversed the ischemia and averted operation. AMAT, however, cannot be cured medically; if vasospasm is observed on arteriography in a patient with AMAT, intra-arterial papaverine may be started to improve flow, but it will not be curative.
Thrombolytic agents infused through the angiography catheter can be life-saving for selected patients with AMAE. Bleeding is the main complication. Thrombolytic administration is risky and should only be undertaken if peritonitis or other signs of bowel necrosis are absent.
The infusion must be started within 8 hours of symptom onset. If symptoms do not improve within 4 hours or if peritonitis develops, the infusion should be stopped and surgical treatment instituted.
Thrombolytics have shown no benefit in AMAT. Lytic therapy with urokinase, streptokinase, or tissue plasminogen activator has been found to be beneficial in some cases of MVT.
Heparin anticoagulation is the main therapy for MVT. If no signs of bowel necrosis exist, the patient may not even need an operation. Heparin may increase the chance of bleeding complications. A possible avenue for randomized clinical trials is the use of enoxaparin or another low-molecular-weight heparin (LMWH) as a potential substitute for heparin in the treatment of MVT.
Heparin is administered first as a bolus of 80 U/kg, not to exceed 5000 U, and then as an infusion at 18 U/kg/hr until full conversion to oral warfarin. Appropriate monitoring of anticoagulation through measurement of the activated partial thromboplastin time (aPTT) is mandatory.
Before operative management of AMI, patients should be stabilized as described above (see Initial Resuscitation and Stabilization). If possible, they should undergo bowel preparation the night before surgery and take nothing by mouth after midnight the evening before surgery.
If the surgeon thinks a patient may require extensive resection and that lifelong hyperalimentation is likely to be the only option, this possibility should be thoughtfully discussed with the patient and the family to help guide the surgeon during the exploration. Such issues are best decided preoperatively, with educated input from the patient, rather than intraoperatively by the surgeon.
It is essential to determine the locations of viable and nonviable bowel during surgery. In patients with AMAT, laparotomy reveals that the entire small bowel and proximal colon are affected, reflecting a proximal obstruction. In patients with AMAE, however, the proximal jejunum is spared, reflecting a more distal obstruction. When extensive bowel involvement is noted, every effort must be made to retain every centimeter of viable bowel. If determining bowel viability is difficult, a second look may be required 24-48 hours later.
Evaluation of viability begins with direct visualization of the bowel. If the first part of the jejunum is not involved, an embolus may be present, and immediate embolectomy may be indicated. Peristalsis should be sought, and the color of the bowel should be observed (pink and healthy vs red and edematous; see the image below). After reconstitution of arterial flow, the viability of the bowel is reassessed. This reassessment is based on clinical findings, including the color of the bowel and the presence or absence of palpable pulses.
Intraoperative Doppler scans of the bowel can provide valuable information on the patency of the vessels. Differentiation of nonviable from viable bowel can be enhanced by intraoperative fluorescein administration. During laparotomy, 1 g of fluorescein is infused. Viable bowel fluoresces brightly under a Wood lamp, thus allowing the surgeon to better identify the segments that must be resected.
Because of fat absorption, fluorescein can be used only once. Most patients can benefit from a 24- to 48-hour second-look operation to assess the viability of the remaining bowel. Intraoperative fluorescein administration may be performed either at the primary operation or during the second-look operation.
A second-look laparotomy is the most reliable method of determining bowel viability. The decision to perform a second-look procedure is made during the initial exploration. If a second look is deemed necessary, the surgeon should not change his or her mind, regardless of the patient’s clinical progress.
Acute mesenteric arterial embolism
For AMAE (ie, embolic AMI), unless the involved bowel is clearly gangrenous, reperfusion should be attempted. The SMA is exposed and isolated below the mesocolon distal to the middle colic artery, and the location of the blockage is determined by palpation of pulses. Because most emboli are near the origin of the middle colic artery, the proximal SMA pulse should be noted in AMAE.
A transverse (or, according to some surgeons’ preference, longitudinal) arteriotomy is made proximal to the point of occlusion, and a balloon-tipped Fogarty catheter (size 3 or 4) is passed distally. The balloon is then inflated and the clot extracted. The arteriotomy can be closed primarily or vein-patched to prevent lumen compromise. If primary closure or patching is difficult, the patient may require an endarterectomy. A bypass may be required if embolectomy is unsuccessful.
After restoration of flow, the intestines are observed for 10-15 minutes to allow assessment of bowel viability. As noted (see above), this assessment can be enhanced by intraoperative duplex ultrasonography, fluorescein use, and palpation of pulses distal to the occlusion.
Other methods of reperfusion involve prosthetic bypass grafting or autogenous vein grafting.
Acute mesenteric arterial thrombosis
Surgical treatment of AMAT (ie, thrombotic AMI) involves exploratory laparotomy, followed by identification of the involved artery and bowel. Anticoagulation therapy with IV heparin, if not already started, should be initiated.
Emergency surgical revascularization is indicated. Simple thrombectomy is of little or no benefit, because most patients have clinically significant atherosclerosis at the time of the acute decompensation. Unlike patients with AMAE, patients with AMAT have a lesion at the origin of the SMA, and no SMA pulsation is detected at the origin.
If the gut is not gangrenous, revascularization may proceed. An antegrade aortomesenteric bypass is preferred. Bypass may also be done with a prosthetic graft. If bowel perforation is discovered on laparotomy, an autogenous saphenous vein graft should be used because of the decreased risk of infection. Transaortic endarterectomy is an alternative when no vein is suitable for harvesting or when a prosthetic graft is contraindicated (eg, with massive fecal contamination).[87, 88] After revascularization, the viability of the bowel is reassessed.
Endovascular therapies have been described, and some authors have tried thromboaspiration. The criterion standard remains operative exploration to allow assessment of bowel viability.
Mesenteric venous thrombosis
For patients with severe MVT, exploratory laparotomy with assessment of bowel viability is indicated (see above). Anticoagulation therapy with IV heparin should be initiated immediately and continued intraoperatively. Definitive surgical treatment is required for patients with signs of bowel infarction or peritonitis.[90, 33] Treatment involves resecting the dead bowel segment(s) and reanastomosing the remaining bowel ends.
Direct venous surgery to remove the clot is usually unsuccessful and is best reserved for patients with portal vein or superior mesenteric vein (SMV) involvement. Thrombectomy has little use in MVT, because it can only be performed if the thrombus is fresh (ie, no more than 1-3 days old) and because the thrombosis is usually so widespread that all the thrombi cannot be removed completely. Mechanical transhepatic thrombectomy has been described in one patient.
To minimize the amount of bowel loss, a second-look laparotomy should be seriously considered, especially in patients with significant bowel involvement. However, unlike patients with mesenteric arterial ischemia, patients with MVT generally do not require a second-look laparotomy unless progression of the disease is observed or suspected (typically ~40% of cases).
Reports of diagnostic laparoscopy in patients with venous thrombosis suggest that this modality may be of some utility in preventing fruitless laparotomies in MVT patients; however, the decreased mesenteric blood flow that occurs with laparoscopy may worsen bowel ischemia.
Patients with severe intestinal loss due to MVT may be considered for intestinal transplantation in specialized centers.
Angioplasty and stenting
Some experience with percutaneous endovascular interventions has been accumulated. A few patients who have atherosclerotic plaques at the origin of the SMA after thrombolysis are eligible for angioplasty. Angioplasty is technically difficult because of the anatomy of the SMA. Restenosis rates are 20-50%. Limited study findings indicate a definite role for angioplasty in the treatment of AMI. A case of successful transcutaneous catheter aspiration of an embolic clot from SMA has been reported.
In select cases, especially in isolated spontaneous dissection of the SMA diagnosed before the onset of intestinal infarction, stent placement has been successful and may constitute the best therapeutic option.[19, 20, 21, 22, 86]
Postoperative care should include close monitoring of blood pressure and hemoglobin level to evaluate for sepsis or hemorrhage. Heparin anticoagulation should be continued postoperatively to reduce thrombotic events. Antibiotics should be continued postoperatively to prevent any septic events. Papaverine may be administered to reduce vasospasm.
A 12-lead electrocardiogram (ECG) should be obtained to evaluate for myocardial dysfunction. Echocardiography should be considered to identify any for valvular vegetations. A workup for a hypercoagulable state is required postoperatively if it was not done preoperatively. Postoperative ileus due to bowel reperfusion should be expected and appropriately managed.
Complications of surgery
Because patients with MVT are typically in a hypercoagulable state, the incidence of deep vein thrombosis (DVT) is increased. Proper anticoagulation and liberal use of sequential compression stockings can help prevent this postoperative complication.
Because of the high incidence of atherosclerosis in patients with AMI, it is not surprising that one of the most common postoperative complications is myocardial infarction (MI). Prevention of postoperative MI involves preoperatively identifying correctable coronary artery disease. A Swan-Ganz catheter may be used during the perioperative period to monitor fluid status and cardiac function. During the cross-clamping of the supraceliac aorta, the anesthesiologist can ensure myocardial protection and afterload reduction to maximize cardiac output.
Because patients become acutely hypovolemic, acute renal failure may occur in the immediate postoperative period. This complication can be prevented by keeping the patient well hydrated and administering mannitol before the aorta is cross-clamped.
Other possible complications include bleeding, infection, bowel infarction, prolonged ileus, and graft infection.
Diet and Activity
To prepare for surgery and to reduce oxygen demand on the ischemic bowel, patients must be on NPO status. No other specific dietary measures are mandatory.
Patients’ activities are dictated by their conditions. Bed rest to allow for monitoring and to reduce demand on cardiac output is balanced against ambulation to prevent DVT.
The following consultations should be considered in the setting of AMI:
Vascular surgeon - To evaluate the patient and to perform a revascularization procedure if required; this consultation should be obtained as soon as the diagnosis is considered
Interventional radiologist - To perform any needed angiographic drug infusions or angioplasty
Critical care specialist - To evaluate the patient for possible insertion of a Swan-Ganz catheter or admission to a critical care unit; patients with AMI are often hemodynamically unstable or highly likely to progress to instability
Because of the high likelihood of concomitant vascular disease in the rest of the arterial tree, patients must be closely monitored. Cardiac and renal status should be determined at follow-up. Carotid duplex studies may be necessary if diffuse atherosclerotic disease is a strong possibility.
Outpatient medications include antiarrhythmics for patients with atrial fibrillation (AF) and warfarin for long-term treatment of patients with MVT or AF. Patients who have had MVT need warfarin therapy for at least 6 months or for life if a hypercoagulable state was discovered during treatment. Patients with AF should also be discharged on warfarin. Patients with other treatable predisposing conditions should be continued on appropriate therapy.
Periodic evaluation of coagulation status is required as well. To ensure proper anticoagulation, patients should have frequent visits for monitoring of the international normalized ratio (INR).
Patients who have had extensive small bowel resection have severe diarrhea for a few weeks, but many appear to be able to compensate for the reduced bowel length after a few months. Thereafter, they may have one to three liquid bowel movements a day and may maintain or gain weight with oral intake. On the other hand, patients who have undergone total resection of the small intestine need lifelong IV hyperalimentation (ie, total parenteral nutrition).
A number of patients who recover from ileus secondary to intestinal ischemia may develop fibrosis of a segment of small bowel with intermittent partial obstruction.
Sachs SM, Morton JH, Schwartz SI. Acute mesenteric ischemia. Surgery. 1982 Oct. 92(4):646-53. [Medline].
Cokkinis AJ. Observations on the mesenteric circulation. J Anat. 1930 Jan. 64:200-205. [Medline].
Mamode N, Pickford I, Leiberman P. Failure to improve outcome in acute mesenteric ischaemia: seven-year review. Eur J Surg. 1999 Mar. 165(3):203-8. [Medline].
Alpern MB, Glazer GM, Francis IR. Ischemic or infarcted bowel: CT findings. Radiology. 1988 Jan. 166(1 Pt 1):149-52. [Medline].
Kim MY, Suh CH, Kim ST, Lee JH, Kong K, Lim TH, et al. Magnetic resonance imaging of bowel ischemia induced by ligation of superior mesenteric artery and vein in a cat model. J Comput Assist Tomogr. 2004 Mar-Apr. 28(2):187-92. [Medline].
Kozuch PL, Brandt LJ. Review article: diagnosis and management of mesenteric ischaemia with an emphasis on pharmacotherapy. Aliment Pharmacol Ther. 2005 Feb 1. 21(3):201-15. [Medline].
Aksu C, Demirpolat G, Oran I, Demirpolat G, Parildar M, Memis A. Stent implantation in chronic mesenteric ischemia. Acta Radiol. 2009 Jul. 50(6):610-6. [Medline].
Penugonda N, Gardi D, Schreiber T. Percutaneous intervention of superior mesenteric artery stenosis in elderly patients. Clin Cardiol. 2009 May. 32(5):232-5. [Medline].
Mitchell EL, Chang EY, Landry GJ, Liem TK, Keller FS, Moneta GL. Duplex criteria for native superior mesenteric artery stenosis overestimate stenosis in stented superior mesenteric arteries. J Vasc Surg. 2009 Aug. 50(2):335-40. [Medline].
Sivamurthy N, Rhodes JM, Lee D. Endovascular versus open mesenteric revascularization: immediate benefits do not equate with short-term functional outcomes. J Am Coll Surg. 2006. 202(6):859-67.
Bertrán X, Muchart J, Planas R, Real MI, Ribera JM, Cabré E, et al. Occlusion of the superior mesenteric artery in a patient with polycythemia vera: resolution with percutaneous transluminal angioplasty. Ann Hematol. 1996 Feb. 72(2):89-91. [Medline].
Schoots IG, Levi MM, Reekers JA, Lameris JS, van Gulik TM. Thrombolytic therapy for acute superior mesenteric artery occlusion. J Vasc Interv Radiol. 2005 Mar. 16(3):317-29. [Medline].
Fink S, Chaudhuri TK, Davis HH. Acute mesenteric ischemia and malpractice claims. South Med J. 2000 Feb. 93(2):210-4. [Medline].
Rosenblum JD, Boyle CM, Schwartz LB. The mesenteric circulation. Anatomy and physiology. Surg Clin North Am. 1997 Apr. 77(2):289-306. [Medline].
Boley SJ. Circulatory responses to acute reduction of superior mesenteric arterial flow. Physiologist. 1969. 12:180.
Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the... Circulation. 2006 Mar 21. 113(11):e463-654. [Medline].
Chang RW, Chang JB, Longo WE. Update in management of mesenteric ischemia. World J Gastroenterol. 2006 May 28. 12(20):3243-7. [Medline].
Leung DA, Schneider E, Kubik-Huch R, Marincek B, Pfammatter T. Acute mesenteric ischemia caused by spontaneous isolated dissection of the superior mesenteric artery: treatment by percutaneous stent placement. Eur Radiol. 2000. 10(12):1916-9. [Medline].
Miyamoto N, Sakurai Y, Hirokami M, Takahashi K, Nishimori H, Tsuji K, et al. Endovascular stent placement for isolated spontaneous dissection of the superior mesenteric artery: report of a case. Radiat Med. 2005 Nov. 23(7):520-4. [Medline].
Ko GJ, Han KJ, Han SG, Hwang SY, Choi CH, Gham CW, et al. [A case of spontaneous dissection of the superior mesenteric artery treated by percutaneous stent placement]. Korean J Gastroenterol. 2006 Feb. 47(2):168-72. [Medline].
Casella IB, Bosch MA, Sousa WO Jr. Isolated spontaneous dissection of the superior mesenteric artery treated by percutaneous stent placement: case report. J Vasc Surg. 2008 Jan. 47(1):197-200. [Medline].
Cappell MS. Intestinal (mesenteric) vasculopathy. I. Acute superior mesenteric arteriopathy and venopathy. Gastroenterol Clin North Am. 1998 Dec. 27(4):783-825, vi. [Medline].
Boley SJ, Brandt LJ, Sammartano RJ. History of mesenteric ischemia. The evolution of a diagnosis and management. Surg Clin North Am. 1997 Apr. 77(2):275-88. [Medline].
Liu JJ, Ardolf JC. Sumatriptan-associated mesenteric ischemia. Ann Intern Med. 2000 Apr 4. 132(7):597. [Medline].
Abu-Daff S, Abu-Daff N, Al-Shahed M. Mesenteric venous thrombosis and factors associated with mortality: a statistical analysis with five-year follow-up. J Gastrointest Surg. 2009 Jul. 13(7):1245-50. [Medline].
Endress C, Gray DG, Wollschlaeger G. Bowel ischemia and perforation after cocaine use. AJR Am J Roentgenol. 1992 Jul. 159(1):73-5. [Medline].
Sudhakar CB, Al-Hakeem M, MacArthur JD, Sumpio BE. Mesenteric ischemia secondary to cocaine abuse: case reports and literature review. Am J Gastroenterol. 1997 Jun. 92(6):1053-4. [Medline].
Bech FR. Celiac artery compression syndromes. Surg Clin North Am. 1997 Apr. 77(2):409-24. [Medline].
Tseng YC, Tseng CK, Chou JW, Lai HC, Hsu CH, Cheng KS, et al. A rare cause of mesenteric ischemia: celiac axis compression syndrome. Intern Med. 2007. 46(15):1187-90. [Medline].
Sanchez LD, Tracy JA, Berkoff D, Pedrosa I. Ischemic colitis in marathon runners: a case-based review. J Emerg Med. 2006 Apr. 30(3):321-6. [Medline].
Agaoglu N, Türkyilmaz S, Ovali E, Uçar F, Agaoglu C. Prevalence of prothrombotic abnormalities in patients with acute mesenteric ischemia. World J Surg. 2005 Sep. 29(9):1135-8. [Medline].
Alvi AR, Khan S, Niazi SK, Ghulam M, Bibi S. Acute mesenteric venous thrombosis: improved outcome with early diagnosis and prompt anticoagulation therapy. Int J Surg. 2009 Jun. 7(3):210-3. [Medline].
Ji M, Yoon SN, Lee W, Jang S, Park SH, Kim DY, et al. Protein S deficiency with a PROS1 gene mutation in a patient presenting with mesenteric venous thrombosis following total colectomy. Blood Coagul Fibrinolysis. 2011 Oct. 22(7):619-21. [Medline].
Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med. 2001 Dec 6. 345(23):1683-8. [Medline].
Abdu RA, Zakhour BJ, Dallis DJ. Mesenteric venous thrombosis--1911 to 1984. Surgery. 1987 Apr. 101(4):383-8. [Medline].
Harward TR, Green D, Bergan JJ, Rizzo RJ, Yao JS. Mesenteric venous thrombosis. J Vasc Surg. 1989 Feb. 9(2):328-33. [Medline].
James AW, Rabl C, Westphalen AC, Fogarty PF, Posselt AM, Campos GM. Portomesenteric venous thrombosis after laparoscopic surgery: a systematic literature review. Arch Surg. 2009 Jun. 144(6):520-6. [Medline].
Wang MQ, Lin HY, Guo LP, Liu FY, Duan F, Wang ZJ. Acute extensive portal and mesenteric venous thrombosis after splenectomy: treated by interventional thrombolysis with transjugular approach. World J Gastroenterol. 2009 Jun 28. 15(24):3038-45. [Medline]. [Full Text].
Stamou KM, Toutouzas KG, Kekis PB, Nakos S, Gafou A, Manouras A, et al. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg. 2006 Jul. 141(7):663-9. [Medline].
Wang MQ, Liu FY, Duan F, Wang ZJ, Song P, Fan QS. Acute symptomatic mesenteric venous thrombosis: treatment by catheter-directed thrombolysis with transjugular intrahepatic route. Abdom Imaging. 2011 Aug. 36(4):390-8. [Medline]. [Full Text].
Cappell MS. Intestinal (mesenteric) vasculopathy. II. Ischemic colitis and chronic mesenteric ischemia. Gastroenterol Clin North Am. 1998 Dec. 27(4):827-60, vi. [Medline].
Ha C, Magowan S, Accortt NA, Chen J, Stone CD. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol. 2009 Jun. 104(6):1445-51. [Medline].
Vokurka J, Olejnik J, Jedlicka V, Vesely M, Ciernik J, Paseka T. Acute mesenteric ischemia. Hepatogastroenterology. 2008 Jul-Aug. 55(85):1349-52. [Medline].
Tallarita T, Oderich GS, Macedo TA, Gloviczki P, Misra S, Duncan AA, et al. Reinterventions for stent restenosis in patients treated for atherosclerotic mesenteric artery disease. J Vasc Surg. 2011 Nov. 54(5):1422-1429.e1. [Medline].
Cardin F, Fratta S, Perissinotto E, Casarrubea G, Inelmen EM, Terranova C, et al. Clinical correlation of mesenteric vascular disease in older patients. Aging Clin Exp Res. 2012 Jun. 24(3 Suppl):43-6. [Medline].
Di Fabio F, Obrand D, Satin R, Gordon PH. Intra-abdominal venous and arterial thromboembolism in inflammatory bowel disease. Dis Colon Rectum. 2009 Feb. 52(2):336-42. [Medline].
Cardin F, Fratta S, Perissinotto E, Casarrubea G, Inelmen EM, Terranova C. Clinical correlation of mesenteric vascular disease in older patients. Aging Clin Exp Res. 2012 Jun. 24(3 Suppl):43-6. [Medline].
Huang HH, Chang YC, Yen DH, Kao WF, Chen JD, Wang LM, et al. Clinical factors and outcomes in patients with acute mesenteric ischemia in the emergency department. J Chin Med Assoc. 2005 Jul. 68(7):299-306. [Medline].
Safioleas MC, Moulakakis KG, Papavassiliou VG, Kontzoglou K, Kostakis A. Acute mesenteric ischaemia, a highly lethal disease with a devastating outcome. Vasa. 2006 May. 35(2):106-11. [Medline].
Schoots IG, Koffeman GI, Legemate DA, Levi M, van Gulik TM. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg. 2004 Jan. 91(1):17-27. [Medline].
Boley SJ, Sprayregen S, Veith FJ, Siegelman SS. An aggressive roentgenologic and surgical approach to acute mesenteric ischemia. Surg Annu. 1973. 5:355-78. [Medline].
Klempnauer J, Grothues F, Bektas H, Pichlmayr R. Long-term results after surgery for acute mesenteric ischemia. Surgery. 1997 Mar. 121(3):239-43. [Medline].
Boley SJ, Sprayregan S, Siegelman SS, Veith FJ. Initial results from an agressive roentgenological and surgical approach to acute mesenteric ischemia. Surgery. 1977 Dec. 82(6):848-55. [Medline].
Nonthasoot B, Tullavardhana T, Sirichindakul B, Suphapol J, Nivatvongs S. Acute mesenteric ischemia: still high mortality rate in the era of 24-hour availability of angiography. J Med Assoc Thai. 2005 Sep. 88 Suppl 4:S46-50. [Medline].
Murray MJ, Gonze MD, Nowak LR, Cobb CF. Serum D(-)-lactate levels as an aid to diagnosing acute intestinal ischemia. Am J Surg. 1994 Jun. 167(6):575-8. [Medline].
Lange H, Jäckel R. Usefulness of plasma lactate concentration in the diagnosis of acute abdominal disease. Eur J Surg. 1994 Jun-Jul. 160(6-7):381-4. [Medline].
Lange H, Toivola A. [Warning signals in acute abdominal disorders. Lactate is the best marker of mesenteric ischemia]. Lakartidningen. 1997 May 14. 94(20):1893-6. [Medline].
Kurt Y, Akin ML, Demirbas S, Uluutku AH, Gulderen M, Avsar K, et al. D-dimer in the early diagnosis of acute mesenteric ischemia secondary to arterial occlusion in rats. Eur Surg Res. 2005 Jul-Aug. 37(4):216-9. [Medline].
Acosta S, Nilsson TK, Bjorck M. Preliminary study of D-dimer as a possible marker of acute bowel ischaemia. Br J Surg. 2001 Mar. 88(3):385-8. [Medline].
Altinyollar H, Boyabatli M, Berberoglu U. D-dimer as a marker for early diagnosis of acute mesenteric ischemia. Thromb Res. 2006. 117(4):463-7. [Medline].
Acosta S, Nilsson TK, Björck M. D-dimer testing in patients with suspected acute thromboembolic occlusion of the superior mesenteric artery. Br J Surg. 2004 Aug. 91(8):991-4. [Medline].
Clark RA, Gallant TE. Acute mesenteric ischemia: angiographic spectrum. AJR Am J Roentgenol. 1984 Mar. 142(3):555-62. [Medline].
Kaufman SL, Harrington DP, Siegelman SS. Superior mesenteric artery embolization: an angiographic emergency. Radiology. 1977 Sep. 124(3):625-30. [Medline].
Böttger T, Schäfer W, Weber W, Junginger T. [Value of preoperative diagnosis in mesenteric vascular occlusion. A prospective study]. Langenbecks Arch Chir. 1990. 375(5):278-82. [Medline].
Boos S. [Angiography of the mesenteric artery 1976 to 1991. A change in the indications during mesenteric circulatory disorders?]. Radiologe. 1992 Apr. 32(4):154-7. [Medline].
Czerny M, Trubel W, Claeys L, Scheuba C, Huk I, Prager M, et al. [Acute mesenteric ischemia]. Zentralbl Chir. 1997. 122(7):538-44. [Medline].
Brandt LJ, Boley SJ. AGA technical review on intestinal ischemia. American Gastrointestinal Association. Gastroenterology. 2000 May. 118(5):954-68. [Medline].
Savassi-Rocha PR, Veloso LF. Treatment of superior mesenteric artery embolism with a fibrinolytic agent: case report and literature review. Hepatogastroenterology. 2002 Sep-Oct. 49(47):1307-10. [Medline].
American Gastroenterological Association Medical Position Statement: guidelines on intestinal ischemia. Gastroenterology. 2000 May. 118(5):951-3. [Medline].
Horton KM, Fishman EK. Multi-detector row CT of mesenteric ischemia: can it be done?. Radiographics. 2001 Nov-Dec. 21(6):1463-73. [Medline].
Cikrit DF, Harris VJ, Hemmer CG, Kopecky KK, Dalsing MC, Hyre CE, et al. Comparison of spiral CT scan and arteriography for evaluation of renal and visceral arteries. Ann Vasc Surg. 1996 Mar. 10(2):109-16. [Medline].
Zeman RK, Silverman PM, Vieco PT, Costello P. CT angiography. AJR Am J Roentgenol. 1995 Nov. 165(5):1079-88. [Medline].
Aschoff AJ, Stuber G, Becker BW, Hoffmann MH, Schmitz BL, Schelzig H, et al. Evaluation of acute mesenteric ischemia: accuracy of biphasic mesenteric multi-detector CT angiography. Abdom Imaging. 2009 May-Jun. 34(3):345-57. [Medline].
Kirkpatrick ID, Kroeker MA, Greenberg HM. Biphasic CT with mesenteric CT angiography in the evaluation of acute mesenteric ischemia: initial experience. Radiology. 2003 Oct. 229(1):91-8. [Medline].
Wiesner W. [Is multidetector computerized tomography currently the primary diagnostic method of choice in diagnostic imaging of acute intestinal ischemia?]. Praxis (Bern 1994). 2003 Jul 30. 92(31-32):1315-7. [Medline].
Vogelzang RL, Gore RM, Anschuetz SL, Blei AT. Thrombosis of the splanchnic veins: CT diagnosis. AJR Am J Roentgenol. 1988 Jan. 150(1):93-6. [Medline].
Barmase M, Kang M, Wig J, Kochhar R, Gupta R, Khandelwal N. Role of multidetector CT angiography in the evaluation of suspected mesenteric ischemia. Eur J Radiol. 2011 Dec. 80(3):e582-7. [Medline].
Ward D, Vernava AM, Kaminski DL, Ure T, Peterson G, Garvin P, et al. Improved outcome by identification of high-risk nonocclusive mesenteric ischemia, aggressive reexploration, and delayed anastomosis. Am J Surg. 1995 Dec. 170(6):577-80; discussion 580-1. [Medline].
Grieshop RJ, Dalsing MC, Cikrit DF, Lalka SG, Sawchuk AP. Acute mesenteric venous thrombosis. Revisited in a time of diagnostic clarity. Am Surg. 1991 Sep. 57(9):573-7; discussion 578. [Medline].
Jona J, Cummins GM Jr, Head HB, Govostis MC. Recurrent primary mesenteric venous thrombosis. JAMA. 1974 Mar 4. 227(9):1033-5. [Medline].
Acosta S, Ogren M, Sternby NH, Bergqvist D, Björck M. Mesenteric venous thrombosis with transmural intestinal infarction: a population-based study. J Vasc Surg. 2005 Jan. 41(1):59-63. [Medline].
Herbert GS, Steele SR. Acute and chronic mesenteric ischemia. Surg Clin North Am. 2007 Oct. 87(5):1115-34, ix. [Medline].
Hansen KJ, Deitch JS. Transaortic mesenteric endarterectomy. Surg Clin North Am. 1997 Apr. 77(2):397-407. [Medline].
Marudanayagam R, Syed S, Nasr H, Fox A. Outcome following mesenteric artery revascularisation for chronic mesenteric ischemia. Minerva Chir. 2011 Apr. 66(2):101-6. [Medline].
Gagnière J, Favrolt G, Alfidja A, Kastler A, Chabrot P, Cassagnes L, et al. Acute thrombotic mesenteric ischemia: primary endovascular treatment in eight patients. Cardiovasc Intervent Radiol. 2011 Oct. 34(5):942-8. [Medline].
Harnik IG, Brandt LJ. Mesenteric venous thrombosis. Vasc Med. 2010 Oct. 15(5):407-18. [Medline].
Takahashi N, Kuroki K, Yanaga K. Percutaneous transhepatic mechanical thrombectomy for acute mesenteric venous thrombosis. J Endovasc Ther. 2005 Aug. 12(4):508-11. [Medline].
Hladík P, Raupach J, Lojík M, Krajina A, Voboril Z, Jon B, et al. Treatment of acute mesenteric thrombosis/ischemia by transcatheter thromboaspiration. Surgery. 2005 Jan. 137(1):122-3. [Medline].
Thomas RM, Ahmad SA. Management of acute post-operative portal venous thrombosis. J Gastrointest Surg. 2010 Mar. 14(3):570-7. [Medline].